These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 4540389

  • 1. Drug-induced pulmonary disease.
    Winkler JW.
    Ann Intern Med; 1973 Apr; 78(4):617. PubMed ID: 4540389
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators.
    Henningsen NC, Cederberg A, Hanson A, Johansson BW.
    Acta Med Scand; 1975 Dec; 198(6):475-82. PubMed ID: 55060
    [Abstract] [Full Text] [Related]

  • 7. [Lupus erythematosus syndrome in the course of procainamide treatment].
    Dabrowska B, Lapińska K, Blaszczyk M.
    Kardiol Pol; 1971 Dec; 14(3):316-20. PubMed ID: 5316267
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The frequency of procainamide-induced systemic lupus erythematosus.
    Hope RR, Bates LA.
    Med J Aust; 1972 Aug 05; 2(6):298-303. PubMed ID: 4117237
    [No Abstract] [Full Text] [Related]

  • 10. [Lupus erythematosus in the course of treatment with procaine amide: report of a case].
    Dabrowska B, Lapińska K, Blaszczyk M.
    Kardiol Pol; 1971 Aug 05; 14(3):317-20. PubMed ID: 5315756
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Procaine-induced lupus erythematosus].
    Waagstein F.
    Nord Med; 1970 Apr 09; 83(15):468-70. PubMed ID: 4193388
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antinuclear antibodies as indicators for the procainamide-induced systemic lupus erythematosus-like syndrome and its clinical presentations.
    Gorsulowsky DC, Bank PW, Goldberg AD, Lee TG, Heinzerling RH, Burnham TK.
    J Am Acad Dermatol; 1985 Feb 09; 12(2 Pt 1):245-53. PubMed ID: 3882781
    [Abstract] [Full Text] [Related]

  • 18. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA.
    N Engl J Med; 1978 May 25; 298(21):1157-9. PubMed ID: 306574
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Large dose procainamide therapy for ventricular tachyarrhythmia.
    Greenspan AM, Horowitz LN, Spielman SR, Josephson ME.
    Am J Cardiol; 1980 Sep 25; 46(3):453-62. PubMed ID: 6968154
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.